Cite Filings / VNDA / 0001628280-26-016516

Feed Companies Filings Check

Sign in

8-K

Current Report

Vanda Pharmaceuticals Inc. Filed 2026-03-10 Acc 0001628280-26-016516

Regulation FD disclosure

Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Documents 1

8-K Current Report , vnda-20260310.htm

Around this filing

2026-04-02 8-K Executive or director change
2026-03-10 8-K Regulation FD disclosure
2026-03-04 4 SVP, Chief Marketing Officer sold 30,800 shares at $8.27 ($254,590)
2026-03-04 4 SVP & General Counsel sold 42,434 shares at $8.27 ($350,755)
2026-03-04 4 SVP, Business Development sold 42,431 shares at $8.27 ($350,730)
2026-03-04 4 President and CEO sold 156,235 shares at $8.17 ($1,276,971)
2026-02-23 8-K Other events

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading vnda-20260310.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…